Emcure Pharmaceuticals saw its shares reach the upper circuit limit of 10 percent on Friday, May 23, 2025, continuing a rally for the third day in a row with an impressive overall gain of nearly 20 ...

Emcure stake buy: Pharma firm to acquire 20.42% in Zuventus for Rs 724.9 crore; full ownership to aid consolidation Exclusive- When Shark Tank India's Namita Thapar reacted to being addressed as 'nepo ...

Emcure Pharmaceuticals IPO subscription status: The initial public offering of Emcure Pharmaceuticals Ltd kickstarts for subscriptions today (Wednesday, July 3). At an upper price range of ₹1,008 per ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Shares of Emcure Pharmaceuticals Ltd surged 8.04 per cent on Monday, touching an intraday high of Rs 1,448, before closing 7.03 per cent higher at Rs 1,434.50. The stock has gained 52.76 per cent over ...

Emcure Pharmaceuticals reported a 48.2% year-on-year growth in net profit to ₹231 crore in the December quarter. This profit after tax (PAT) includes an exceptional expense of ₹38 crore related to ...

Shares of Emcure Pharmaceuticals Ltd surged 7.61 per cent in Monday's trade to hit a high of Rs 1,464.70 after the company announced a partnership with Novo Nordisk India to launch Poviztra, a ...

Emcure Pharmaceuticals on Wednesday posted a 48 per cent year-on-year increase in its consolidated profit after tax at ₹231 crore for the third quarter ended December 31, 2025, led by robust sales ...

Just five months after Novo Nordisk launched Wegovy in India, the Danish company has partnered (PDF) with Emcure Pharmaceuticals to increase access to the weight-loss treatment in the nation. Emcure, ...

The shares of Emcure Pharmaceuticals jumped nearly 3 percent to hit a fresh record high on January 7, before erasing all gains to close in the red. An analyst has suggested which key levels investors ...

Mar 09, 2026, 6:59 PM IST Emcure Pharma. - Announcement under Regulation 30 (LODR)-Change in Management Mar 09, 2026, 6:38 PM IST Emcure Pharma. - Board Meeting Outcome for Outcome Of Board Meeting ...